Search
for
Sort by
Research 31–60 of 1000+
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Skin Biology and Ageing
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- 24 ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Miscellaneous Topics in Disorders of Endocrine Glands
- Symptom Experience of Lung Cancer Patients Treated With Immunotherapy Combined with Chemotherapy: A Longitudinal Study
- Biological therapy in the treatment of melanoma
- Nanomedicine-based immunotherapy for tissue regeneration
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- A bibliometric analysis of T cell and atherosclerosis
- Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings
- PV-0538 Prostaglandin related distinct regenerative activities in hair follicles following radiation injury
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Folate receptor β performs an immune checkpoint function in activated macrophages
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Immune therapies for alopecia areata: evidence and new perspectives
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes